pathology - search results

3Deus Dynamics has raised €2.5 million for the industrialization of its 3D process, to expand internationally and revolutionize personalized medicine with Dynamic Molding.

Professor Shaw-Ruey Lyu from the School of Medicine, Tzu-Chi University, discusses Knee Pain and Osteoarthritis (Knee OA) Treatment Research, in particular Knee Health Promotion Option (KHPO).

Susanne Zeilinger studied Microbiology and Genetics at the University of Vienna where she also received her PhD She gained experience in production and characterization of Trichoderma reesei extracellular proteins during a stay at the VTT Technical Research Center of Finland and pioneered the utilization of molecular biological and genetic engineering...

The current primary treatment for hypophosphatasia is enzyme replacement therapy; however the development of a new gene therapy drug, ARU-2801, may change the landscape forever.

Dr. Ermita Hernandez obtained a master's degree in Plant Pathology and a doctoral degree in Horticultor with a minor in Entomology from The Pennsylvania State University She started her professional carrier as an Assistant professor at the University of Puerto Rico in 2014 where her research and extension program focus...

Henri Huttunen, Chief Scientific Officer, Herantis Pharma Plc, charts progress in the development of disease-modifying treatments for Parkinson’s disease.

The Government launched its new Science and Technology framework to cement the UK’s place as a science and tech superpower by 2030.

Suspected cancer patients in England are currently referred to the NHS urgent cancer referral pathway, known as the ‘2-week wait’ (2WW). It guarantees that suspected cancer patients can see a specialist in Secondary Care within 14 days of referral.

Professor Michael Levin from Imperial College London argues that in the DIAMONDS project, there has been a breakthrough response in personalized medicine via RNA molecular signature diagnosis.

Bradlee Heckmann, PhD, from USF Health Neuroscience Institute, Byrd Alzheimer’s Center & Asha Therapeutics, in this discussion goes beyond amyloid, asking what’s next for Alzheimer’s Disease therapeutics.

CEO of ViewMind Inc, Mark Edwards, discusses overcoming global inequities in cognitive healthcare to combat the dementia epidemic.

AI offers an opportunity to reimagine our approach to cancer diagnostics, leveraging data to build a more robust and efficient system for cancer referrals.

Professor Laura Grenville-Briggs shares her stance on working together to counter the threat of oomycete diseases, focussing on trans-sectoral approaches to support sustainable plant and crop production systems in Europe Oomycetes, microbes that superficially resemble fungi, are devastating pathogens affecting a wide range of plants and animals. Oomycete diseases in...

Why migrating to public cloud computing is essential to achieve Net Zero targets and drive meaningful change in the UK public sector.

Hamilton Hall MD FRCSC, Executive Director, Canadian Spine Society/Back Care Canada, helps us to understand back pain, leg pain and how to manage the problem.

Tim Simpson, General Manager of Hologic UK & Ireland, discusses how AI, machine learning and prognostics could revolutionise cancer detection and treatment in breast and cervical cancer programmes.

Wendy Harrison, CEO of the SCI Foundation, outlines the importance of putting parasitic infections on the map, with a particular focus on schistosomiasis.

In recent years, the use of military burn pits has become one of the most widely discussed concerns about both current service members and veterans’ health.

Professor Laura Grenville-Briggs shares her stance on working together to counter the threat of oomycete diseases, focussing on trans-sectoral approaches to support sustainable plant and fish production systems in Europe.

Cardiometabolic disease (CMD) refers to a cluster of inter-related factors, including obesity, high blood pressure, high blood sugar, and elevated cholesterol (1).